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Abstract
Background: Determination of PC20-FEV1 during Methacholine bronchial provocation test (MCT)
is considered to be impossible in preschool children, as it requires repetitive spirometry sets. The
aim of this study was to assess the feasibility of determining PC20-FEV1 in preschool age children
and compares the results to the wheeze detection (PCW) method.
Methods: 55 preschool children (ages 2.8–6.4 years) with recurrent respiratory symptoms were
recruited. Baseline spirometry and MCT were performed according to ATS/ERS guidelines and the
following parameters were determined at baseline and after each inhalation: spirometry-indices,
lung auscultation at tidal breathing, oxygen saturation, respiratory and heart rate. Comparison
between PCW and PC20-FEV1 and clinical parameters at these end-points was done by paired
Student's t-tests.
Results and discussion: Thirty-six of 55 children (65.4%) successfully performed spirometry-sets
up to the point of PCW. PC20-FEV1 occurred at a mean concentration of 1.70+/-2.01 while PCW
occurred at a mean concentration of 4.37+/-3.40 mg/ml (p < 0.05). At PCW, all spirometry-
parameters were markedly reduced: FVC by 41.3+/-16.4% (mean +/-SD); FEV1 by 44.7+/-14.5%;
PEFR by 40.5+/-14.5 and FEF25–75 by 54.7+/-14.4% (P < 0.01 for all parameters). This reduction was
accompanied by de-saturation, hyperpnoea, tachycardia and a response to bronchodilators.
Conclusion: Determination of PC20-FEV1 by spirometry is feasible in many preschool children.
PC20-FEV1 often appears at lower provocation dose than PCW. The lower dose may shorten the
test and encourage participation. Significant decrease in spirometry indices at PCW suggests that
PC20-FEV1 determination may be safer.
Background
Measurements of bronchial hyper-reactivity (BHR) have
provided insight into the physiological basis of asthma,
and provide a tool for asthma diagnosis, assessment of
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asthma severity and response to treatment [1,2]. The
bronchial provocation tests require an objective outcome
measurement that reflects airway function. Forced expira-
tory volume in 1 second (FEV1) has been standardized to
measure changes in airway caliber that occur with bron-
chial provocation [3]. In the Methacholine challenge test
(MCT), the provocative concentration reducing FEV1 by
20% from baseline (PC20-FEV1) is considered the end
point of the test. Traditionally, spirometry in young chil-
dren has been difficult to achieve. Therefore, techniques
that do not require cooperation (i.e., detection of wheeze
during normal breathing, a fall of 5% in O2-saturation
(SaO2), or an increase of 50% in respiratory rate and/or
heart rate) have been used as alternative end points in
bronchial provocation tests in the preschool age [4-7].
Recently it has been shown that young children can be
taught to perform reliable forced expiratory maneuvers [8-
11]. Yet, it is unclear whether these young children have
the drive to perform and tolerate repetitive reproducible
spirometry-sets that are measured during the interval
between inhalations. Concentration of methacholine
(MCH) causing wheeze, a fall of 5% in O2- Saturation, an
increase of 50% in respiratory rate and/or heart rate
(PCW) and PC20-FEV1 were compared in school children
and a good correlation was found between the two meth-
ods [7,12-14].
This study assesses the ability of young asthmatic pre-
school children to cooperate with repetitive spirometry-
sets during MCT, and thereby allow determination of
PC20-FEV1 in comparison with PCW.
Methods
Subjects
Consecutive preschool children referred to the Pediatric
Pulmonary Clinic, Meyer Children's Hospital, Rambam
Medical Center, Haifa, over a 6-month period were
recruited. Of 62 families offered participation in the
study, seven refused. None of the children had experi-
enced spirometry previously. Inclusion criteria were: 2.5–
6.5 year-old children who were asthmatic according to
GINA guidelines [15] with recurrent episodes of wheeze,
cough and/or shortness of breath with clinical response to
bronchodilator; normal chest auscultation and FEV1
>75% of predicted for healthy preschool children [9] after
saline inhalation. Exclusion criteria were: presence of other
chronic respiratory conditions; emergency room visit in
the past three months; respiratory infection in the past
month; oral or inhaled steroids or other anti-inflamma-
tory medication taken in the last week; bronchodilator
taken within 24 hours prior to the test.
The Rambam Medical Center Ethics Board approved the
study. Parental consent was obtained for each child.
Methacholine challenge
Tests were performed in a designated room at the Pediatric
Pulmonary Unit, Meyer Children's Hospital, Haifa, Israel.
A parent and the investigating team (a pediatric pulmo-
nary physician, respiratory physiologist and technician)
were present throughout the test. MCT was performed
according to published guidelines, [3], with doubling
doses of fresh Methacholine solutions (0.06 to 8.00 mg/
ml) dissolved in saline. Solutions were driven by com-
pressed air of 5 l/min flow (giving a mean output of 0.4
ml/min), and nebulized using a Hudson nebulizer (Hud-
son RCI, Temecula, CA, USA). Inhalations were per-
formed using a facemask while the child was sitting up
straight and breathing normally. Nebulized Methacholine
was inhaled for 2 minutes, with 5-minute intervals
between doses, until the maximal concentration or the
end point was reached. To ensure safety in light of the risk
of airway closer, the MCH increment was only half the
usual amount when transient wheeze or cough was noted,
keeping in mind that the accumulative dose is affected by
this manipulation. Oxygen saturation and heart rate were
monitored continuously by pulse oximetry (Biox 3700e;
Ohmeda). A single observer (LB) performed auscultation
for 20 seconds over the trachea and two zones of both
lungs (upper front and lower back) according to Springer
et al. [7]
The following indices were considered "end of test":
appearance of audible wheeze, a fall of ≥5% in O2-satura-
tion, or an increase of ≥50% in respiratory rate and/or
heart rate [7]. At the "end of test", spirometric measure-
ments were performed, followed by administration of
nebulized Albuterol (2.5 mg).
Spirometry
Forced expiratory flow volume (FEFV) curves were meas-
ured with a ZAN100 commercial spirometer (ZAN Mess-
geraete GmbH, Oberthulba, Germany). Calibration was
performed before the testing sessions. The curves were
monitored on the computer screen to ensure best effort.
Results were corrected to BTPS conditions. The software
included an interactive animated computer game (Spiro-
Game®) set by targets of the FEFV maneuver, combining
forced inhalation preceding forced expiration, peak expir-
atory flow rate (PEFR) and forced vital capacity (FVC)
with emphasis on prolonged expiration. [8] The targets
were the extrapolated values derived from comparative
data from older children, corrected for height. [16] An
experienced pulmonary technician instructed each child
how to operate the game. Teaching time was limited to 15
minutes. On-line rejection of curves was based on visual
inspection for "non-cooperation" errors and included:
poor effort; incomplete expiration; cough; glottis closure.
Curves had to show a rapid rise to peak flow, and gradual,
smooth decline of flow down to residual volume. BaselineBMC Pediatrics 2005, 5:19 http://www.biomedcentral.com/1471-2431/5/19
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maneuvers were repeated to visually obtain best possible
efforts on at least 3 technically acceptable FEFV curves.
After obtaining baseline spirometry, MCT was performed.
A duplicate spirometry set was performed immediately
after auscultation. PC20-FEV1 was determined off line by
the provocative concentration that reduced FEV1 by 20%
from baseline. PC values were log-transformed before sta-
tistical analyses. Spirometry indices included FVC, FEV1,
PEFR, forced expiratory flow at 50% FVC (FEF50), FEV1/
FVC ratio.
Analysis and statistics
Three baseline spirometry curves were analyzed for
acceptability criteria according to ATS/ERS guidelines
[17,18] and in comparison with similar data for preschool
children [11,19]. These included: a) "Start of test" criteria:
time to peak expiratory flow and backward extrapolated
volume (Vbe) b) "End of test criteria": described by "total
expiratory time" and the ratio of "no change in expiratory
volume" to "total expiratory time" c) reproducibility
(coefficient of variation) of the three baseline curves, cal-
culated as SD/mean*100.
After inhalations, the curves were inspected visually
online, and were analyzed offline in relation to baseline
using paired t-test. Differences were considered significant
when p < 0.05. The level of agreement between the dose
at end of test and the dose of PC20 were compared by
Bland and Altman analysis (20).
Results
A total of 55 children (28F/27M, age range 2.8–6.4 years)
were recruited. Eleven children failed spirometry and
underwent MCT by auscultation only. Failure to perform
spirometry was due to lack of comprehension (4 children)
or failure to repeat spirometry after baseline measure-
ments (7 children). Failure was not age dependent. Eight
children refused to cooperate with either test. Thirty-six of
55 (65.5%) children performed the MCT with spirometry
tests and with auscultation. Of these 36 children, eleven
were 2.5–3.9 years old, 15 were 4–5 years old, and 10
were >5 years old. Three children failed to produce FEV1
on the baseline measurements but were able to produce it
after saline administration. In these children, post saline
FEV1 measurements were considered as baseline. FEV1 at
that point was >75% predicted. The anthropometric data
and baseline lung function of the 36 patients are pre-
sented in Table 1 and clinical characteristics in Table 2.
The 36 children participating in both tests had a previous
response to bronchodilators as judged by clinical observa-
tion. The average duration of respiratory symptoms was
18 ± 14 weeks. Five children were not receiving any med-
ication for a period of weeks. Nine children were receiving
bronchodilators as needed, and 22 were using both
inhaled steroids and bronchodilators as needed.
Quality of baseline maneuvers: Start of test: Peak expira-
tory flow rates were reached within a mean of 98 ± 7 ms
(range 89–115 ms) and mean Vbe was 3.4 ± 1.5% of FVC
(range 1.2–5.7). Intra-subject reproducibility for the base-
line triple maneuvers was: for FVC, 4.1 ± 2.3% (range 1.8–
6.3); for FEV1, 3.8 ± 2.3% (range 0.4–7.3); for PEFR, 4.4 ±
2.8% (range 0.3–8.6) and for FEF25–75, 7.9 ± 3.5% (range
2.7–13.2). End of test: Mean expiratory time was 1.48 ±
0.47 seconds and the ratio of "no change in expiratory-
volume" to "total expiration time" was 0.20 ± 0.06.
MCT test
Children's response to MCT (n = 36) is summarized in
Figure 1 and Table 3. Average test time to reach PC20-FEV1
was 29 ± 11 minutes, while for PCW it was 41 ± 10 min-
utes (not including bronchodilator administration) (p <
0.001). The end point of the challenge was determined by
Table 1: Anthropometric data and lung function. The results are expressed as mean ± SD.
Anthropometric data Baseline lung function %predicted [16]
N Height (cm) Weight (kg) Sex (M/F) FVC FEV1 FEV1/FVC PEFR FEF50
36 104 ± 7 18 ± 3 20/16 95 ± 15 91 ± 14 96 ± 3 99 ± 14 101 ± 16
Table 2: Clinical Characteristics
N = 36 Recurrent cough Recurrent lung 
infiltrates
Shortness of 
breath
Wheezing Atopy Family history of 
allergy
N3 52 42 41 61 62 3BMC Pediatrics 2005, 5:19 http://www.biomedcentral.com/1471-2431/5/19
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the pediatric pulmonologist as positive in 35/36 children.
One child did not display any of the determined criteria
for PCW up to 8 mg/ml and was considered to have no
BHR. The mean (± SD) concentration at PCW for the 36
children was 4.26± 3.31 mg/ml. Wheezing at the end
point was observed in 26/36 children and in 9/36 the test
was ended before the appearance of wheeze due to either
oxygen desaturation or tachypnea accompanied by audi-
ble long expiration. Mean increase in heart rate at PCW
was 25.5 ± 11% (range 10–42%); respiratory rate
increased by 30.0 ± 21.1% (range 0–42%) and SaO2
decreased by 6.3 ± 2.7% (range 2.3–10.3%).
PC20-FEV1  occurred at a mean concentration value of
1.96- ± 1.83 mg/ml. The one child who did not respond
to MCH of up to 8 mg/ml by PCW (negative BHR) did not
show a fall of 20% from baseline FEV1 value either. The
other 35 children exhibited a fall of 20% in FEV1 from
baseline values in response to MCH ≤8 mg/ml (Figure 1
and Table 3). A representative set of FEFV curves from a
single patient that includes the predicted curve, baseline,
PC20-FEV1 and end of test curves is shown in Figure 2.
Table 3: Appearance of respiratory distress signs at PCW and PC20-FEV1
Symptom Cough Wheeze Prolonged Audible 
Expiration
Decrease SaO2 Increased HR Increased RR
# Children at PCW 32 26 24 33 28 25
# Children at PC20-FEV1 28 2 7 15 3 7
Number of children responding to each MCH concentration  (mg/ml) at PCW and at PC20-FEV1 Figure 1
Number of children responding to each MCH concentration 
(mg/ml) at PCW and at PC20-FEV1
A representative example of forced expiratory flow-volume  curves from one child Figure 2
A representative example of forced expiratory flow-volume 
curves from one child. Predicted, Baseline, PC20-FEV1 and 
PCW curves are presented
Table 4: Changes in respiratory indices at PCW and at PC20-
FEV1. The results are expressed as mean ± SD. (n = 35/36, as one 
child did not respond to MCH and his spirometry did not change 
throughout the test).
Parameter End of test PC20-FEV1
FVC - 41.3 ± 15.5 - 18.4 ± 10.0 *
FEV1 - 44.7 ± 14.5 - 24.6 ± 6.4 *
FEV1/FVC - 6.09 ± 6.8 - 4.1 ± 3.8 *
PEFR - 44.2 ± 13.2 - 21.4 ± 10.6 *
FEF50 - 61.2 ± 14.2 - 38.6 ± 16.9 *
Expiratory time (sec) +2.8 ± 0.4 +2.2 ± 0.4 *
* Changes at PC20-FEV1 are significantly lower than at "end of test", p 
< 0.01BMC Pediatrics 2005, 5:19 http://www.biomedcentral.com/1471-2431/5/19
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At PC20-FEV1 there was a mean increase in heart rate of
13.5 ± 11.0%, respiratory rate increased by 15.4 ± 15.8%
and SaO2 decreased by 2.4 ± 2.1% from baseline level.
These changes were significantly lower than those found
at PCW (p < 0.01 for three parameters). The appearance of
PC20-FEV1 occurred 2 concentrations earlier than PCW in
5 children, 1.5-concentrations earlier in 3 children, one
concentration earlier in 17 children, 0.5 concentrations
earlier in 3 children and at the same concentration as
PCW in 7 children (Figure 1). The effects of MCH on the
spirometry parameters are presented in Table 4. At PC20-
FEV1, parameters were moderately decreased, while at end
point, test parameters were markedly reduced. The sever-
ity of FEV1 reduction at PCW was variable, ranging from
30.8 to 68.2% of baseline. The level of agreement between
the dose at end of test (PCW) and the dose at PC20[20] is
presented in Figure 3. Dotted lines represent 95% coeffi-
cient of variation values.
Bronchodilators improved FEV1 by 43 ± 29% from PCW
values and all respiratory symptoms disappeared shortly
after bronchodilator administration.
Discussion
In this study we assessed the feasibility of determining
PC20-FEV1  during Methacholine bronchial provocation
testing in asthmatic preschool children. We found MCT
was feasible in 65% of this group of wheezy preschool
children. Children as young as 3 years old complied and
cooperated with what seems to be a most fatiguing proce-
dure. Baseline measurements met most of the ATS criteria
for older children and adults [17,18] and quality control
studies on spirometry in preschool children [11,19]. We
found that PC20-FEV1  correlates with PCW. However,
PC20-FEV1  frequently precedes PCW. All spirometry
parameters at PC20-FEV1 were significantly higher than
those measured at PCW.
In this study, we used interactive spirometry games [8]
with multiple spirometry targets, since single targeted
games (usually peak expiratory flow targeted) have not
fulfilled expectations [21,22]. Our teaching method is
supported by the findings that 65% of the children fully
cooperated not only with baseline measurements but also
with spirometry sets. Of note, 26 of the 36 children were
younger than 5 years. Conforming quality control was
necessary to proceed with the test. The quality control of
baseline spirometry in our study met most ATS/ERS crite-
ria concerning reproducibility and start of test criteria
[17,18] and matched those reported for preschool chil-
dren [11,19], encouraging us to continue with the MCT
test. Vbe = 5%FVC found in our study is narrower than
reported [11], as we have rejected in advance curves with
Vbe >5%FVC at the expense of success rate. It should be
stressed that our work did not compare verbal coaching
[9] or other spirometry games [11,23] as the preferable
methodology for keeping the child going and performing
repetitive spirometry sets.
The mean PC20-FEV1 of 1.96 ± 1.83 mg/ml found in our
group reflects a mild degree of BHR, as we recruited chil-
dren with mild asthmatic symptoms. Our findings for
PC20-FEV1 are comparable to those of Hayden et al [13],
who found a mean PC20-FEV1 at FEV0.5 of 2.49 ± 2.55 mg/
ml in infants. Adinoff et al [24] reported a mean provoca-
tive dose of 3.0 mg/ml Methacholine in their preschool
children and infants. Tepper [25] et al. reported that
infants with asthma-like respiratory symptoms might
respond to MCH concentrations as low as 1.25 mg/ml. In
that respect we found that PC20-FEV0.5 occurred at a mean
concentration value of 1.29- ± 1.47 mg/ml, meaning that
the responsiveness of the airways in the preschool age
may be similar to that of infants, despite differences in the
measurement techniques. It is important to note that
PC20-FEV0.5 occurred at a significant mean lower concen-
tration than PC20-FEV1 (1.96- ± 1.83 mg/ml; p < 0.01),
however, standardization is needed to accept the PC20-
FEV0.5  value for the determination of hyper-reactive
airways.
PCW
We found that PCW occurred in our group at a mean con-
centration of 4.26 ± 3.31 mg/ml. PCW values in our study
were much higher than the PCW (0.4 mg/ml) reported by
Springer et al [7]. The difference may be attributed to
inclusion of more severe asthmatics in their study group.
Analysis of the difference in dose values at end of test (PCW)  and the dose at PC20, as compared with mean Dose values of  the two, in a Bland and Altman analysis (20) Figure 3
Analysis of the difference in dose values at end of test (PCW) 
and the dose at PC20, as compared with mean Dose values of 
the two, in a Bland and Altman analysis (20). Dotted lines 
represent 95% coefficient of variation values.BMC Pediatrics 2005, 5:19 http://www.biomedcentral.com/1471-2431/5/19
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Spirometry at PCW
We found that PC20-FEV1 occurred at a lower concentra-
tion than PCW in most subjects. This finding is in agree-
ment with several other studies comparing PCW detection
to PC20-FEV1 in school age children. [4-7,14]. However, in
none of these studies were spirometry measurements
carried out to the point of wheeze. We expected to find a
good correlation between the two tests (PCW =
1.2195*PC20-FEV1 + 0.0288; R2 = 0.9733; p < 0.005), yet
the Blant and Altman analysis revealed that in children
with higher mean provocation PCW dose (≥6 mg), the
level of agreement between the methods was low, reflect-
ing higher sensitivity of the PC20 method, especially in
mild airway reactivity (Figure 3).
We found that at PCW, FEFV curves visually seemed to be
smaller and all parameters were reduced simultaneously
(Figure 2), with a highly significant reduction in flows and
volume parameters. The reduction in curve was gradual in
most children, accompanied by an increase in respiratory
symptoms (Table 2), and responded to bronchodilators,
and hence was not considered to reflect fatigue. To further
strengthen this point a representative curve of one child
illustrating, a poor effort performed at teaching process vs.
end of test curve is shown in figure 4. The poor-effort
curve did not fulfill start of test criteria and is round while
the "end of test curve" has an obstructed shape.
The reduced FVC and flows are most likely due to a severe
degree of airway narrowing involving small to medium
airways that may be accompanied by air trapping, partial
closure of airways and elevation in FRC. Reduced FVC
may also be due to increased glottic narrowing due to
MCH irritation [26,27], but the flow volume curve was
not suggestive of upper airway obstruction (trimmed
PEFR). Alternatively, the upper airways response to meth-
acholine may contribute to the increase in total respira-
tory resistance [27]. This pattern occurred in some cases
before appearance of wheeze or other clinical end-points.
Indeed, in 9/36 subjects, the test was terminated due to
oxygen desaturation or tachypnea rather than wheeze.
Similar to our results, Sprikkelman et al [28] reported that
wheeze was detected in only 33% of 15 school-age asth-
matic children at PC20-FEV1, and Springer et al [7] termi-
nated the test without the presence of wheeze in 19.2% of
young children. In this respect we would argue that FEV1
does make a contribution beyond simply asking the
subject if they wheeze. Novitzki et al (4) found in 5–8
year-old children that FEV1 is decreased by 33.3 ± 7.4% at
PCW. Spence et al [29] reported a mean fall of 51 ± 14%
from baseline FEV1  when wheeze appeared in their
asthmatic older subjects. Our results strengthen these
prior findings, and suggest that spirometric PC20-FEV1
may be achieved with inhalation of lower MCH concen-
trations than those used to achieve wheeze.
Measuring PCW during tidal volume breathing has the
advantage that no active cooperation on the child's part is
needed. Therefore the success rate of PCW is higher than
spirometry (44/55 children). However, using PC20-FEV1
(or PC20-FEV0.5) can preclude inhalation of higher con-
centrations of MCH used to achieve wheeze, leading to
alarmingly diminished flows found at PCW and a signifi-
cant shortening of test time relative to PCW.
Conclusion
We conclude that PC20-FEV1 is feasible in preschool asth-
matic children when using respiratory games teaching
techniques and that the children tolerate repetitive dupli-
cate sets of spirometry maneuvers. PC20-FEV1 in preschool
children appears to be as sensitive as in adults and school
children. Yet, many questions remain open as to the use-
fulness of this test in a random sample of young children
and/or how discriminating this test is as a diagnostic tool.
It would also be necessary to assess the sensitivity of this
test to various severities of disease. Further studies are
needed for standardization and definition of methodo-
logical criteria.
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